NewAmsterdam Pharma Company N.V. Ordinary Shares
NAMS •
Buy Open
Signal type
Buy
Status
Open
Open Price
$33.43
Stop Loss
$30.84
Performance
3.04%
Days Open
14
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 1, 2026
Open Price $33.43
Stop Loss $30.84
Timespan Day
Company Profile
Name NewAmsterdam Pharma Company N.V. Ordinary Shares
Ticker NAMS
Market Cap $2.03B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $34.44
List Date Nov 23, 2022
Description
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Website Open Company Website